• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER; NRY Back to Search Results
Model Number 5MAXACE132-A
Medical Device Problem Code Fracture (1260)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/08/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Event or Problem Description
The patient was undergoing a thrombectomy procedure in the basilar artery using a penumbra system ace 60 reperfusion catheter (ace60).During the procedure, the physician finished an angiography inspection.Then, while inserting an ace60 into the rotating hemostasis valve (rhv), the physician noticed that the distal end of the ace60 was fractured.Therefore, the ace60 was removed.The procedure was completed using a non-penumbra catheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Please note that the following section was incorrectly reported on the initial mfr report and is being corrected on this follow-up # 01 mfr report: 1.Section g.Box 3.Report source.Evaluation of the returned ace60 confirmed that the catheter was fractured.Further evaluation revealed stress marks at the fractured location.This indicates that the catheter likely kinked prior to the fracture.If the ace60 is forcefully advanced against resistance or otherwise mishandled during use, damage such as a kink and subsequent fracture may occur.Penumbra catheter are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SYSTEM 5MAX ACE REPERFUSION CATHETER
Common Device Name
NRY
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
MDR Report Key11621554
Report Number3005168196-2021-00696
Device Sequence Number3262758
Product Code NRY
UDI-Device Identifier00814548017426
UDI-Public00814548017426
Combination Product (Y/N)Y
Initial Reporter CountryCH
PMA/510(K) Number
K160449
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/28/2021
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/19/2022
Device Model Number5MAXACE132-A
Device Catalogue Number5MAXACE132
Device Lot NumberF90428
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/25/2021
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 03/10/2021
Supplement Date Received by Manufacturer07/21/2021
Initial Report FDA Received Date04/06/2021
Supplement Report FDA Received Date07/28/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age65 YR
Date Report Sent to FDA01/01/2005
-
-